Home/Pipeline/OpRegen® (RG6501)

OpRegen® (RG6501)

Geographic Atrophy Secondary to AMD

Phase IIActive, not recruitingNCT05626140

Key Facts

Indication
Geographic Atrophy Secondary to AMD
Phase
Phase II
Status
Active, not recruiting
Company

About Bayer

Bayer AG's mission is 'Health for all, Hunger for none,' focusing on advancing healthcare and food security through science-led innovation. The company has achieved significant scale and diversification, most notably through the transformative acquisition of Monsanto, establishing a leading position in agricultural sciences. Its strategy centers on driving growth in its core pharmaceutical pipeline—particularly in oncology, cardiology, and cell & gene therapy—while navigating legacy legal challenges and optimizing its portfolio to enhance shareholder value and operational focus.

View full company profile